Olivier Guillin Selected Research

Olivier Guillin Research Topics

Disease

9	Schizophrenia (Dementia Praecox) 07/2022 - 11/2002
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2024 - 01/2022
3	Treatment-Resistant Depressive Disorder 01/2024 - 01/2022
3	Mental Disorders (Mental Disorder) 07/2022 - 11/2002
2	Neurodevelopmental Disorders 10/2023 - 01/2022
2	Mania (Manias) 01/2023 - 11/2015
2	Autistic Disorder (Autism) 12/2018 - 02/2010
2	Autism Spectrum Disorder 12/2018 - 06/2011
2	Hallucinations (Hallucination) 01/2018 - 09/2013
2	Parkinson Disease (Parkinson's Disease) 11/2003 - 11/2002
1	Wounds and Injuries (Trauma) 01/2024
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023
1	Glioma (Gliomas) 01/2023
1	Postpartum Depression (Post-Natal Depression) 07/2022
1	Depressive Disorder (Melancholia) 07/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 07/2022
1	Headache (Headaches) 01/2022
1	Asthenia 01/2022
1	Conversion Disorder (Astasia Abasia) 01/2022
1	Paralysis (Palsy) 01/2022
1	Treatment-Resistant Schizophrenia 04/2021
1	Asperger Syndrome (Asperger's Syndrome) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Alcoholism (Alcohol Abuse) 02/2017
1	Multiple Sclerosis 11/2015
1	Cognitive Dysfunction 10/2015
1	Movement Disorders (Movement Disorder) 10/2015
1	Dementia (Dementias) 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Weight Gain 06/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2011
1	Tachycardia (Tachyarrhythmias) 06/2011
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2010
1	Catatonia 12/2008
1	Dyskinesias (Dyskinesia) 11/2003
1	Substance-Related Disorders (Drug Abuse) 11/2002

Drug/Important Bio-Agent (IBA)

5	Antipsychotic Agents (Antipsychotics)IBA 04/2021 - 01/2007
4	Clozapine (Clozaril)FDA LinkGeneric 04/2021 - 02/2010
3	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2022
3	Dopamine (Intropin)FDA LinkGeneric 01/2007 - 11/2002
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2007 - 11/2002
2	EsketamineIBA 01/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2014
2	Dopamine D3 ReceptorsIBA 11/2003 - 11/2002
1	Nasal SpraysIBA 01/2024
1	Leucine (L-Leucine)FDA Link 01/2023
1	TESIBA 07/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	NucleotidesIBA 01/2020
1	CannabinoidsIBA 09/2019
1	CreatinineIBA 09/2019
1	PlacebosIBA 01/2018
1	Baclofen FDA LinkGeneric 02/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2015
1	Methylprednisolone FDA LinkGeneric 11/2015
1	GadoliniumIBA 11/2015
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2015
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2010
1	Tramadol (K315)FDA LinkGeneric 12/2008
1	Nerve Growth Factors (Neurotrophins)IBA 01/2007
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2003
1	Levodopa (L Dopa)FDA LinkGeneric 11/2003
1	Therapeutic UsesIBA 11/2003

Therapy/Procedure

3	Transcranial Magnetic Stimulation 01/2023 - 01/2018
2	Therapeutics 09/2019 - 11/2003
1	Transcranial Direct Current Stimulation 07/2022
1	Activities of Daily Living (ADL) 01/2014